NSC |
Compound |
Enrichment |
Correlation |
NSC 710530 |
Null |
0.00227238673876898 |
0.19937885 |
NSC 698088 |
Null |
0.00306027196853062 |
-0.1547582 |
NSC 731154 |
6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno [1,2-c]isoquinoline |
0.00306027196853062 |
-0.0080730542 |
NSC 732937 |
6-(3-Azidopropyl)-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline |
0.00306027196853062 |
-0.06100413 |
NSC 742295 |
(11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one |
0.00306027196853062 |
0.22316705 |
NSC 685272 |
D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone |
0.00347157511980527 |
0.041101221 |
NSC 689140 |
1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 9-methyl-5-phenyl- |
0.00347157511980527 |
0.33394701 |
NSC 623794 |
1,4-Benzodioxin-2-carboxamide, 6-(4-oxo-4-H-1- benzopyran-2-yl)-N-(3-pyridinylmethyl)- |
0.00347157511980532 |
0.11406764 |
NSC 357704 |
Cyanomorpholinodoxorubicin |
0.00404192617431249 |
0.21153571 |
NSC 661421 |
Null |
0.00404192617431249 |
-0.26050553 |